Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2009 2
2010 2
2011 2
2012 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
A study of variations in the reported haemophilia A prevalence around the world.
Stonebraker JS, Bolton-Maggs PH, Soucie JM, Walker I, Brooker M. Stonebraker JS, et al. Haemophilia. 2010 Jan;16(1):20-32. doi: 10.1111/j.1365-2516.2009.02127.x. Epub 2009 Oct 21. Haemophilia. 2010. PMID: 19845775
The objectives of this paper were to study the reported haemophilia A prevalence (per 100 000 males) on a country-by-country basis and address the following: Does the reported prevalence of haemophilia A vary by national economies? We collected prevalence data for 1 …
The objectives of this paper were to study the reported haemophilia A prevalence (per 100 000 males) on a country-by-country basis an …
A study of reported factor IX use around the world.
Stonebraker JS, Bolton-Maggs PH, Brooker M, Farrugia A, Srivastava A. Stonebraker JS, et al. Haemophilia. 2011 May;17(3):446-55. doi: 10.1111/j.1365-2516.2010.02461.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21299742
We obtained data on the reported number of international units (IUs) of FIX used for 90 countries from the Marketing Research Bureau and the World Federation of Hemophilia. ...Given these trends, there will likely be an overall increase in the amount of FIX concentrates us …
We obtained data on the reported number of international units (IUs) of FIX used for 90 countries from the Marketing Research Bureau and the …
A study of reported factor VIII use around the world.
Stonebraker JS, Brooker M, Amand RE, Farrugia A, Srivastava A. Stonebraker JS, et al. Haemophilia. 2010 Jan;16(1):33-46. doi: 10.1111/j.1365-2516.2009.02131.x. Epub 2009 Oct 21. Haemophilia. 2010. PMID: 19845774
Data on the reported FVIII use for 104 countries were obtained from the Marketing Research Bureau, Inc. and the World Federation of Hemophilia. ...Such information is critical for national healthcare agencies to determine realistic budget priorities in planning for an incr …
Data on the reported FVIII use for 104 countries were obtained from the Marketing Research Bureau, Inc. and the World Federation of Hemop
Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand.
Stonebraker JS, Amand RE, Bauman MV, Nagle AJ, Larson PJ. Stonebraker JS, et al. Haemophilia. 2004 Jan;10(1):18-26. doi: 10.1046/j.1365-2516.2003.00841.x. Haemophilia. 2004. PMID: 14962216
Sufficient and consistent supply of FVIII concentrates and appropriate financing of haemophilia care will allow the clinical benefits of more aggressive treatment regimens such as prophylaxis to be realized....
Sufficient and consistent supply of FVIII concentrates and appropriate financing of haemophilia care will allow the clinical benefits …
A study of variations in the reported haemophilia B prevalence around the world.
Stonebraker JS, Bolton-Maggs PH, Michael Soucie J, Walker I, Brooker M. Stonebraker JS, et al. Haemophilia. 2012 May;18(3):e91-4. doi: 10.1111/j.1365-2516.2011.02588.x. Epub 2011 Jun 7. Haemophilia. 2012. PMID: 21649801
The objectives of this article were to study the reported prevalence of haemophilia B (HB) on a country-by-country basis and to analyse whether the prevalence of HB varied by national economy. ...We collected data on the HB prevalence for 105 countries from the World Feder …
The objectives of this article were to study the reported prevalence of haemophilia B (HB) on a country-by-country basis and to analy …
A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community.
Stonebraker JS, Amand RE, Nagle AJ. Stonebraker JS, et al. Haemophilia. 2003 May;9(3):245-50. doi: 10.1046/j.1365-2516.2003.00758.x. Haemophilia. 2003. PMID: 12694513
Available data on FVIII concentrate consumption and health-economic indicators were used to calculate index values for FVIII use and economic capacity so each country can assess and compare its level of FVIII concentrate consumption with the economic resources of other countries …
Available data on FVIII concentrate consumption and health-economic indicators were used to calculate index values for FVIII use and economi …
Feedback